Peripheral blood progenitor cell mobilization in patients with primary refractory lymphoma or at first relapse: Comparison with patients at diagnosis and impact on clinical outcome

British Journal of Haematology

Volumn 99, Issue 1, 1997, Pages 41-46

  Tarella, C ^a   Castellino, C ^a   Cherasco, C ^a   Bondesan, P ^a   Giaretta, F ^a   Corradini, P ^a   Caracciolo, D ^a   Gavarotti, P ^a   Pileri, A ^a  

^a Divisione di Ematologia   (Italy)

Author keywords

Lymphoid malignancies; PBPC autograft; Progenitor mobilization; Salvage treatment

Indexed keywords

CYCLOPHOSPHAMIDE; ETOPOSIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CELL MOTILITY; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0030775816     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3433157.x     Document Type: Article

References (29)

1. Bensinger, W.I., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., Gooley, T., Lynch, M., Higano, T., Klarnet, J., Chauncey, T., Storb, R. & Buckner, C.D. (1994) Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematology, 87, 825-851.
2. Bregni, M., Siena, S., Di Nicola, M., Dodero, A., Peccatori, F., Ravagnani, F., Danesisni, G., Lanfranchi, A., Bonadonna, G. & Gianni, A.M. (1996) Comparative effect of granulocyte-macrophage-colony stimulating factor and granulocyte-colony stimulating factor after high-dose cyclophosphamide cancer therapy. Journal of Clinical Oncology, 14, 628-635.
3. Brugger, W., Birken, R., Bertz, H., Hecht, T., Pressler, K., Frish, J., Schulz, G., Mertelsmann, R. & Kanz, L. (1993) Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin. British Journal of Haematology, 84, 402-407.
4. Brugger, W., Heimfeld, S., Berenson, R.J., Mertelsmann, R. & Kanz, L. (1995) Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. New England Journal of Medicine, 333, 283-287.
5. Caracciolo, D., Gavarotti, P., Aglietta, M., Bondesan, P., Falda, M., Gallo, E., Locatelli, F., Novarino, A., Paolino, F., Sanavio, F., Urgesi, A., Vitolo, U. & Tarella, C. (1993) High-dose sequential (HDS) chemotherapy with blood and marrow cell autograft as salvage treatment in very poor prognosis, relapsed non-Hodgkin's lymphoma. Bone Marrow Transplantation, 12, 621-625.
6. Craig, J.I.O., Anthony, R.S., Stewart, A., Thomson, E.B., Gillon, J. & Parker, A.C. (1993) Peripheral blood stem cell mobilization using high-dose cyclophosphamide and G-CSF in pretreated patients with lymphoma. British Journal of Haematology, 85, 210-212.
7. Dreger, P., Kloss, M., Petersen, B., Haferlach, T., Lofller, H., Loefller, M. & Schmitz, N. (1995) Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts. Blood, 86, 3970-3978.
8. Dreyfus, F., Leblond, V., Belanger, C., Gabarre, J., Sutton, L., Boccaccio, C., Quarre, M.C., Ribrag, V. & Goy, A. (1992). Peripheral blood stem cell collection and autografting in high risk lymphomas. Bone Marrow Transplantation, 10, 409-413.
9. Gianni, A.M. (1994) Where do we stand with respect to the use of peripheral blood progenitor cells? Annals of Oncology, 5, 781-784.
10. Gianni, A.M., Bregni, M., Siena S., Brambilla, C., Di Nicola, M., Lombardi, F., Gandola, L., Tarella, C., Pileri, A., Ravagnani, F., Valagussa, P., Bonadonna, G., Stern, A., Magni, M. & Caracciolo, D. (1997) High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. New England Journal of Medicine, 336, 1290-1297.
11. Gianni, A.M., Siena S., Bregni, M., Lombardi, F., Gandola, L., Di Nicola, M., Magni, M., Peccatori, F., Valagussa, P. & Bonadonna, G. (1993) High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease: a 6-year update. Annals of Oncology, 4, 889-891.
12. Gianni, A.M., Siena, S., Bregni, M., Tarella, C., Stern, A.C., Pileri, A., & Bonadonna, G. (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoietic stem cells for autotransplantation. Lancet, ii, 580-585.
13. Haas, R., Mohle, R., Fruhauf, S., Goldschmidt, H., Witt, B., Flentje, M., Wannenmacher, M. & Hunstein, W. (1994) Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83, 3787-3794.
14. Linch, D.C., Winfield, D., Goldstone, A.H., Moir, D., Hancock, B., McMillan, A., Chopra, R., Milligan, D. & Vaughan Hudson, G. (1993) Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet, 341, 1051-1054.
15. Mahendra, P., Johnson, D., Hood, I.M., Scott, M.A., Barker, P., Bass, G., Jestice, H.K., Bloxham, D.M., Boraks, P., Wimperis, J.Z., Baglin, T.P. & Marcus, R.E. (1996) High-dose therapy and autologous stem cell rescue for poor risk and refractory lymphoma: a single centre experience of 125 patients. Bone Marrow Transplantation, 17, 973-978.
16. Pettengell, R., Testa, N.G., Swindell, R., Crowther, D. & Dexter, T.M. (1993) Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma. Blood, 82, 2239-2248.
17. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Vander Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. & Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
18. Scott, M.A., Ager, S., Jestice, H.K., Mahendra, P. & Marcus, R.E. (1995) Failure to mobilise and harvest PBPC does not necessarily preclude the use of high-dose therapy and autologous stem cell rescue. Bone Marrow Transplantation, 15, 487-488.
19. Shimazaki, C., Oku, N., Ashihara, E., Okawa, K., Goto, H., Inaba, T., Ito, K., Fujita, N., Tsuji, H., Murakami, S., Haruyama, H., Nishio, A. & Nakagawa, M. (1992) Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor. Bone Marrow Transplantation, 10, 341-346.
20. Siena, S., Bregni, M., Brando, B., Belli, N., Ravagnani, F., Gandola, L., Stern, A.C., Lansdorp, P.M., Bonadonna, G. & Gianni, A.M. (1991) Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood, 77, 400-409.
21. Siena, S., Bregni, M., Di Nicola, M., Ravagnani, F., Peccatori, F., Gandola, L., Lombardi, F., Tarella, C., Bonadonna, G. & Gianni, A.M. (1994) Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. Annals of Oncology, 5, 935-941.
22. Tarella, C., Caracciolo, D., Gavarotti, P., Bondesan, P., Cherasco, C., Omedè, P., Bregni, M., Siena, S., Gianni, A.M. & Pileri, A. (1995a) Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization. Bone Marrow Transplantation, 16, 223-228.
23. Tarella, C., Ferrero, D., Bregni, M., Siena, S., Gallo, E., Pileri, A. & Gianni, A.M. (1991) Peripheral blood expansion of early progenitor cells after high-dose cyclophosphamide and rhGM-CSF. European Journal of Cancer, 27, 22-27.
24. Tarella, C., Ferrero, D., Siena, S., Gallo, E., Bondesan, P., Bregni, M., Pileri, A. & Gianni, A.M. (1990) Conditions influencing the expansion of the circulating hemopoietic progenitor cell compartment. Haematologica, 75, 11-14.
25. Tarella, C., Gavarotti, P., Caracciolo, D., Corradini, P., Cherasco, C., Castellino, C., Gallo, E. & Pileri, A. (1995b) Haematological support of high-dose sequential chemotherapy: clinical evidence for reduction of toxicity and high response rate in poor risk lymphomas. Annals of Oncology, 6, 3-8.
26. To, L.B., Dyson, P.G. & Juttner, C.A. (1986) Cell-dose effect in circulating stem-cell autografting. Lancet, ii, 404-405.
27. Vose, J.M., Anderson, J.R., Kessinger, A., Bierman, P.J., Coccia, P., Reed, E.C., Gordon, B. & Armitage, J.O. (1993) High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology, 11, 1846-1851.
28. Weaver, C.H., Hazelton, B., Birch, R., Palmer, P., Allen, C., Schwartzberg, L. & West, W. (1995) An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collection in 692 patients after the administration of myeloablative chemotherapy. Blood, 86, 3961-3969.
29. Weaver, C.H., Schwartzberg, L., Li, W., Hazelton, B. & West, W. (1996) High-dose chemotherapy and autologous peripheral blood progenitor cell transplant for the treatment of Hodgkin's disease. Bone Marrow Transplantation, 17, 715-721.